异常EVI1剪接促进EVI1重排白血病
研究在inv(3)/t(3;3)急性髓系白血病中发现一种由SF3B1突变产生的新的EVI1剪接异构体;该异构体在EVI1第二锌指结构域3'端插入6个氨基酸,可增强造血干细胞自我更新,并在人源化inv(3)(q21q26)小鼠中加速白血病发生。
要点
- inv(3)/t(3;3)髓系肿瘤中SF3B1突变率>30%,是最高频的共现基因组改变。
- 突变SF3B1促进EVI1错误剪接,生成第二锌指结构域3'端插入6个氨基酸的异构体。
- 该EVI1剪接变体增强造血干细胞自我更新,并在小鼠中加速白血病发生。
核心结论
- inv(3)/t(3;3)急性髓系白血病中频繁共现的SF3B1突变通过异常剪接产生新的致癌EVI1异构体,直接促进白血病转化,为这类白血病发病机制提供机制基础。
研究设计与样本
- 研究对MECOM(MDS1和EVI1复合位点)进行基因组与表观基因组分析,并在inv(3)/t(3;3)急性髓系白血病患者、患者来源细胞系及人源化inv(3)(q21q26)小鼠模型中开展功能验证。
主要发现
- SF3B1突变在inv(3)/t(3;3)髓系肿瘤患者中发生率>30%,是这类患者中最常见的共现基因组改变。
- SF3B1突变在inv(3)/t(3;3)髓系肿瘤患者及患者来源细胞系中较其他类型AML呈统计学独特富集。
- 突变SF3B1促进EVI1错误剪接,在EVI1第二锌指结构域3'端产生6个氨基酸的框内插入。
- 该EVI1剪接变体增强造血干细胞自我更新。
- 在人源化inv(3)(q21q26)小鼠中引入突变SF3B1可产生该新型EVI1异构体并加速体内白血病发生。
关键数值与推荐
- 突变SF3B1剪接体依赖EVI1外显子13内的外显子剪接增强子,促进隐匿分支点及内含子12内异常3'剪接位点的使用,从而生成该异构体。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Detailed genomic and epigenomic analyses of MECOM (the MDS1 and EVI1 complex locus) have revealed that inversion or translocation of chromosome 3 drives inv(3)/t(3;3) myeloid leukemias via structural rearrangement of an enhancer that upregulates transcription of EVI1. Here, we identify a novel, previously unannotated oncogenic RNA-splicing derived isoform of EVI1 that is frequently present in inv(3)/t(3;3) acute myeloid leukemia (AML) and directly contributes to leukemic transformation. This EVI1 isoform is generated by oncogenic mutations in the core RNA splicing factor SF3B1, which is mutated in >30% of inv(3)/t(3;3) myeloid neoplasm patients and thereby represents the single most commonly cooccurring genomic alteration in inv(3)/t(3;3) patients. SF3B1 mutations are statistically uniquely enriched in inv(3)/t(3;3) myeloid neoplasm patients and patient-derived cell lines compared with other forms of AML and promote mis-splicing of EVI1 generating an in-frame insertion of 6 amino acids at the 3' end of the second zinc finger domain of EVI1. Expression of this EVI1 splice variant enhanced the self-renewal of hematopoietic stem cells, and introduction of mutant SF3B1 in mice bearing the humanized inv(3)(q21q26) allele resulted in generation of this novel EVI1 isoform in mice and hastened leukemogenesis in vivo. The mutant SF3B1 spliceosome depends upon an exonic splicing enhancer within EVI1 exon 13 to promote usage of a cryptic branch point and aberrant 3' splice site within intron 12 resulting in the generation of this isoform. These data provide a mechanistic basis for the frequent cooccurrence of SF3B1 mutations as well as new insights into the pathogenesis of myeloid leukemias harboring inv(3)/t(3;3).
引用
- Tanaka A, Nakano TA, Nomura M, et al. Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia. Blood. 2022. PMID: 35709354. doi:10.1182/blood.2021015325
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。